Louisville, Ky.-based Norton Heart & Vascular Institute performed Kentucky’s first transcatheter tricuspid valve replacement using the Evoque system.
The catheter-based procedure, developed by Edwards Lifesciences, treats severe tricuspid regurgitation and offers a less invasive alternative to open-heart surgery. The Evoque valve is the first transcatheter therapy approved by the FDA for this condition, according to a Dec. 11 Norton Healthcare news release.
The procedure reduces symptoms and improves recovery time. Two successful implantations were completed Dec. 9, according to the release.
